Mueller Lena Karin, Halstenberg Laura, Di Gallo Nicole, Kipping Thomas
Merck Life Science KGaA, Frankfurter Straße 250, 64293 Darmstadt, Germany.
Pharmaceutics. 2023 Oct 27;15(11):2542. doi: 10.3390/pharmaceutics15112542.
Amorphous solid dispersions (ASDs) enable formulations to improve the solubility of poorly soluble active pharmaceutical ingredients (APIs). The amorphous state is reached through the disruption of the crystalline lattice of an API resulting in an increased apparent solubility with faster disintegration. Nevertheless, this form is characterized by a high-energy state which is prone to re-crystallization. To ensure a stable ASD, excipients, e.g., polymers that form a matrix in which an API is dispersed, are used. The applicable polymer range is usually linked to their solubility in the respective solvent, therefore limiting the use of hydrophilic polymers. In this work, we show the applicability of the hydrophilic polymer, polyvinyl alcohol (PVA), in spray-dried solid dispersions. Using a three-fluid nozzle approach, this polymer can be used to generate ASDs with a targeted dissolution profile that is characterized by a prominent spring and desired parachute effect showing both supersaturation and crystallization inhibition. For this purpose, the polymer was tested in formulations containing the weakly basic drug, ketoconazole, and the acidic drug, indomethacin, both classified as Biopharmaceutics Classification System (BSC) class II drugs, as well as the weakly basic drug ritonavir classified as BCS IV. Furthermore, ritonavir was used to show the enhanced drug-loading capacity of PVA derived from the advantageous viscosity profile that makes the polymer an interesting candidate for spray drying applications.
无定形固体分散体(ASDs)能使制剂提高难溶性活性药物成分(APIs)的溶解度。通过破坏API的晶格形成无定形状态,从而使表观溶解度增加,崩解加快。然而,这种形式具有高能态的特点,容易重新结晶。为确保ASD的稳定性,需使用辅料,例如形成基质使API分散其中的聚合物。适用的聚合物范围通常与其在相应溶剂中的溶解度相关,因此限制了亲水性聚合物的使用。在本研究中,我们展示了亲水性聚合物聚乙烯醇(PVA)在喷雾干燥固体分散体中的适用性。采用三流体喷嘴方法,该聚合物可用于制备具有靶向溶出曲线的ASDs,其特征为显著的突释和所需的滞后效应,兼具过饱和和结晶抑制作用。为此,在含有弱碱性药物酮康唑、酸性药物吲哚美辛(二者均归类为生物药剂学分类系统(BSC)II类药物)以及归类为BCS IV类的弱碱性药物利托那韦的制剂中对该聚合物进行了测试。此外,利托那韦用于展示PVA因有利的粘度特性而具有的增强载药能力,这使该聚合物成为喷雾干燥应用的一个有吸引力的候选材料。